Insulin Resistance and Postprandial Endothelial Function: Does Early Intervention Make a Difference?
Phase of Trial: Phase IV
Latest Information Update: 07 Dec 2018
Price : $35 *
At a glance
- Drugs Nateglinide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 29 Nov 2018 Status changed from recruiting to completed.
- 28 Feb 2017 New trial record